PMID: 38876May 1, 1979

Finger tremor and extrapyramidal side effects of neuroleptic drugs

The British Journal of Psychiatry : the Journal of Mental Science
P CollinsP Tyrer

Abstract

Finger tremor and extrapyramidal side-effects (EPSEs) were measured in seven patients before and during neuroleptic drug treatment to assess the relationship between the onset of EPSEs and changes in finger tremor spectra. Tremor and EPSEs were also measured in twelve patients stabilized on neuroleptic drugs to determine whether tremor could provide a reliable index of the presence and severity of extrapyramidal system disturbance. A downward shift in peak tremor frequently was noted within 48 hours of starting neuroleptic drug therapy, usually before the onset of EPSEs, and a significant negative relationship between the severity of EPSEs and tremor frequency (but not tremor amplitude). The peak frequency of finger tremor is thus a sensitive index of extrapyramidal disturbance and might be of value in predicting which patients taking neuroleptic drugs need anti-parkinsonian therapy.

References

Apr 1, 1991·Psychiatry Research·P B VrtunskiH Y Meltzer
Dec 1, 1984·Neuroscience Research·H Shinozaki
May 18, 2010·Science & Justice : Journal of the Forensic Science Society·Abdulaziz Al-Musa Alkahtani, Andrew W G Platt
Mar 1, 1981·British Journal of Clinical Pharmacology·A V Mackay
Jul 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·P TyrerC Trotter
Feb 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·P TyrerI Lee
Jul 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·S Pullinger, P Tyrer

Citations

Jun 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·R H MindhamR Bradley
Jun 1, 1975·Journal of Medical Genetics·P Tyrer, J Kasriel
Dec 5, 1970·Lancet·P FlemingK R Hunter
Jul 1, 1974·Electroencephalography and Clinical Neurophysiology·P Tyrer, A J Bond
Aug 1, 1969·Electroencephalography and Clinical Neurophysiology·C D MarsdenR S Watson
Oct 1, 1974·Archives of General Psychiatry·P Tyrer, M H Lader
Nov 1, 1970·Psychosomatics·A DiMascio, E Demirgian
Mar 1, 1968·Acta paediatrica Scandinavica·G MeeuwisseN Tryding
Dec 1, 1965·Journal of Neurology, Neurosurgery, and Psychiatry·J R Carrie
Aug 1, 1967·The Journal of Physiology·G G Sutton, K Sykes
Aug 1, 1953·Biochimica Et Biophysica Acta·J J CAMPBELLB A EAGLES
Nov 1, 1956·Journal of Neurology, Neurosurgery, and Psychiatry·J MARSHALL, E G WALSH
Nov 1, 1957·Journal of Neurology, Neurosurgery, and Psychiatry·J W REDFEARN
Mar 1, 1963·Journal of Applied Physiology·J E RANDALL, J M METZGER
Apr 1, 1886·The Journal of Physiology·E A Schäfer
Jul 1, 1945·Journal of Neurology, Neurosurgery, and Psychiatry·J D P GRAHAM

Related Concepts

Antipsychotic Effect
Neuroleptic Malignant Syndrome
Fingers
Lenticulostriate Disorders
Antipsychotic Agents
Tremor
Electrophysiology (Science)
Extrapyramidal System
Basal Ganglia Diseases
Static Tremor

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

British Journal of Clinical Pharmacology
P J Tyrer
Electroencephalography and Clinical Neurophysiology
F Oppel, W U Umbach
British Journal of Clinical Pharmacology
J P Leff
© 2020 Meta ULC. All rights reserved